Abstract
Polycystic ovarian syndrome (PCOS) is a highly prevalent condition affecting reproductive-aged women, causing insulin resistance, hyperandrogenism, weight gain, and menstrual problems. The present study intended to investigate the potential role of fisetin (FT) in letrozole (LZ)–induced PCOS in adult female rats and the possible mechanism underlying its action. PCOS was induced by oral administration of LZ (1 mg/kg) for 21 days. Treated rats received FT (1.25 or 2.5 mg/kg) orally once daily for 14 consecutive days. Following the experimental duration, blood samples and ovary tissues were isolated and preserved for biochemical and histopathological examinations. The results revealed that LZ-induced PCOS led to significant abnormalities in sex hormones and metabolic parameters. Additionally, it initiated an inflammatory cascade, evidenced by activation of the NF-κB p65/IL-1β and AMPK/PI3K/AKT pathways, alongside downregulation of Nrf2 ovarian gene expression and NLRP3 inflammasome activity, which enhanced the production of proinflammatory cytokines. FT demonstrated its beneficial impacts by restoring hormonal disturbance and reversing the imbalanced metabolic parameters. Moreover, FT increased the mRNA of ovarian Nrf2 levels and suppressed the up-regulated inflammatory IL-1β/NF-κB p65 signaling pathway, consequently alleviating the elevated levels of ovarian NLRP3. The histopathological examination also confirmed that FT has a beneficial effect in ameliorating PCOS, consistent with the aforementioned parameters. Finally, the present results demonstrated that FT ameliorates LZ-induced PCOS through the intricate interplay between the AMPK/PI3K/AKT-mediated Nrf2 antioxidant defense mechanism and the regulation of the inflammasome NLRP3/NF-κB p65/IL-1β signaling pathways.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Abdallah ABE, El-Ghannam MA, Hasan AA et al (2023) Selenium nanoparticles modulate steroidogenesis-related genes and improve ovarian functions via regulating androgen receptors expression in polycystic ovary syndrome rat model. Biol Trace Elem Res. https://doi.org/10.1007/s12011-023-03616-0
Akintoye OO, Ajibare AJ, Omotuyi IO (2023) Virgin coconut oil reverses behavioral phenotypes of letrozole-model of PCOS in Wistar rats via modulation of NRF2 upregulation. J Taibah Univ Med Sci 18:831–841. https://doi.org/10.1016/j.jtumed.2022.12.020
ALTamimi JZ, BinMowyna MN, AlFaris NA et al (2021) Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R. Saudi Pharm J 29:27–42. https://doi.org/10.1016/j.jsps.2020.12.003
Aswar MK, Deshpande UV, Aswar U (2021) Galactomannan restore letrozole induced polycystic ovarian syndrome (PCOS) in rat model. Am J Pharmacol Toxicol 16:25–32. https://doi.org/10.3844/ajptsp.2021.25.32
Che Y, Yu J, Li Y-S et al (2023) Polycystic ovary syndrome: challenges and possible solutions. J Clin Med 12:1500. https://doi.org/10.3390/jcm12041500
Chełchowska M, Jurczewska J, Gajewska J et al (2023) Antioxidant defense expressed as glutathione status and Keap1-Nrf2 system action in relation to anthropometric parameters and body composition in young women with polycystic ovary syndrome. Antioxidants 12:730. https://doi.org/10.3390/antiox12030730
Cordaro M, D’Amico R, Fusco R et al (2022) Discovering the effects of Fisetin on NF-κB/NLRP-3/NRF-2 molecular pathways in a mouse model of vascular dementia induced by repeated bilateral carotid occlusion. Biomedicines 10:1448. https://doi.org/10.3390/biomedicines10061448
Desai NR, Shrank WH, Fischer MA et al (2012) Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med 125:302.e1-302.e7. https://doi.org/10.1016/j.amjmed.2011.07.033
Guo R, Zheng H, Li Q et al (2022) Melatonin alleviates insulin resistance through the PI3K/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome. Reprod Biol 22:100594. https://doi.org/10.1016/j.repbio.2021.100594
Huang X, Liu G, Guo J, Su Z (2018) The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14:1483–1496. https://doi.org/10.7150/ijbs.27173
Ibrahim YF, Alorabi M, Abdelzaher WY et al (2022) Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother 149:112870. https://doi.org/10.1016/j.biopha.2022.112870
Kabel AM, Ashour AM, Omar MS, Estfanous RS (2020) Effect of fish oil and telmisartan on dehydroepiandrosterone-induced polycystic ovarian syndrome in rats: the role of oxidative stress, transforming growth factor beta-1, and nuclear factor kappa B. Food Sci Nutr 8:5149–5159. https://doi.org/10.1002/fsn3.1819
Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20:3328. https://doi.org/10.3390/IJMS20133328
Khudair N, Agouni A, Elrayess MA et al (2020) Letrozole-loaded nonionic surfactant vesicles prepared via a slurry-based proniosome technology: Formulation development and characterization. J Drug Deliv Sci Technol 58:101721. https://doi.org/10.1016/j.jddst.2020.101721
Li T, Mo H, Chen W et al (2017) Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci 24:646–655. https://doi.org/10.1177/1933719116667606
Liang Y, Zhou Y, Shen P (2004) NF-kappaB and its regulation on the immune system. Cell Mol Immunol 1:343–350
Lim SS, Hutchison SK, Van Ryswyk E et al (2019) Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 3:CD007506. https://doi.org/10.1002/14651858.CD007506.pub4
Liu M, Zhu H, Zhu Y, Hu X (2021) Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol 270:113821. https://doi.org/10.1016/j.jep.2021.113821
Long M, Zhou J, Li D et al (2015) Long-term over-expression of neuropeptide Y in hypothalamic paraventricular nucleus contributes to adipose tissue insulin resistance partly via the Y5 receptor. PLoS ONE 10:e0126714. https://doi.org/10.1371/journal.pone.0126714
Mari A, Ahrén B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529. https://doi.org/10.1097/01.mco.0000171130.23441.59
Mihanfar A, Nouri M, Roshangar L, Khadem-Ansari MH (2021) Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome. J Steroid Biochem Mol Biol 213:105954. https://doi.org/10.1016/j.jsbmb.2021.105954
Murri M, Luque-Ramírez M, Insenser M et al (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19:268–288. https://doi.org/10.1093/humupd/dms059
Nasif EM, Madi MM (2019) Effect of crocin on letrozole-induced polycystic ovarian syndrome. Med J Cairo Univ 87:5237–5243. https://doi.org/10.21608/mjcu.2019.89762
Ortega-Molina A, Lopez-Guadamillas E, Mattison JA et al (2015) Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys. Cell Metab 21:558–570. https://doi.org/10.1016/j.cmet.2015.02.017
Prasath GS, Pillai SI, Subramanian SP (2014) Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats. Eur J Pharmacol 740:248–254. https://doi.org/10.1016/j.ejphar.2014.06.065
Qiu Z, Dong J, Xue C et al (2019) Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway. J Ethnopharmacol 250:111965. https://doi.org/10.1016/j.jep.2019.111965
Rani R, Chitme HR, Kukreti N et al (2023) Regulation of insulin resistance, lipid profile and glucose metabolism associated with polycystic ovary syndrome by Tinospora cordifolia. Nutrients 15:2238. https://doi.org/10.3390/nu15102238
Rizk FH, Soliman NA, Abo-Elnasr SE et al (2022) Fisetin ameliorates oxidative glutamate testicular toxicity in rats via central and peripheral mechanisms involving SIRT1 activation. Redox Rep 27:177–185. https://doi.org/10.1080/13510002.2022.2116551
Rudnicka E, Duszewska AM, Kucharski M et al (2022) Oxidative stress and reproductive function: oxidative stress in polycystic ovary syndrome. Reproduction 164:F145–F154. https://doi.org/10.1530/REP-22-0152
Rudrapal M, Khairnar SJ, Khan J et al (2022) Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol 13. https://doi.org/10.3389/fphar.2022.806470
Ryter SW (2019) Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation. Arch Biochem Biophys 678:108186. https://doi.org/10.1016/j.abb.2019.108186
Sanad A (2013) Prevalence of polycystic ovary syndrome among fertile and infertile women in Minia Governorate, Egypt. Int J Gynecol Obstet 125. https://doi.org/10.1016/j.ijgo.2013.09.025
Sun Y, Zhou S, Guo H et al (2020) Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metab - Clin Exp 102. https://doi.org/10.1016/j.metabol.2019.154002
Sun Y, Qin H, Zhang H et al (2021) Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells. Food Nutr Res 65. https://doi.org/10.29219/fnr.v65.6355
Swanson KV, Deng M, Ting JPY (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477–489. https://doi.org/10.1038/s41577-019-0165-0
Taheri M, Roudbari NH, Amidi F, Parivar K (2022) Investigating the effect of Sulforaphane on AMPK/AKT/NRF2 pathway in human granulosa-lutein cells under H2O2-induced oxidative stress. Eur J Obstet Gynecol Reprod Biol 276:125–133. https://doi.org/10.1016/j.ejogrb.2022.07.006
Wang W, Zheng J, Cui N et al (2019) Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase. J Ovarian Res 12:109. https://doi.org/10.1186/s13048-019-0585-2
Xu J, Dun J, Yang J et al (2020) Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monit 26:e923073-1-e923073-13. https://doi.org/10.12659/MSM.923073
Yan J, Deng D, Wu Y et al (2020) Catalpol protects rat ovarian granulosa cells against oxidative stress and apoptosis through modulating the PI3K/Akt/mTOR signaling pathway. Biosci Rep 40:BSR20194032. https://doi.org/10.1042/BSR20194032
Yu J, Ding C, Hua Z et al (2021) Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway. J Obstet Gynaecol Res 47:1789–1803. https://doi.org/10.1111/jog.14730
Author information
Authors and Affiliations
Contributions
The authors declare that all data were generated in-house and that no paper mill was used. All authors contributed equally to the conception and design of the study. They have all write, read, and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Moustafa, P.E., Abo El Nasr, N.M.E., Shabana, M.E. et al. Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways. Naunyn-Schmiedeberg's Arch Pharmacol (2024). https://doi.org/10.1007/s00210-024-03124-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00210-024-03124-5